Allyl Isothiocyanate AITC.

Isothiocyanates are only released when myrosinase hydrolyses their parent glucosinolate, and heat destroys that enzyme. A myrosinase-active plant material eaten alongside a heat-processed glucosinolate source restores the conversion step. Reviews of glucosinolate bioavailability make this the central determinant of how much isothiocyanate is actually formed.

Sulforaphane and allyl isothiocyanate are both electrophilic isothiocyanates that modify cysteine residues on Keap1 and allow Nrf2 to move to the nucleus. They also share the glutathione conjugation route out of the body, so a large combined load draws on one thiol pool. Additive on the signalling side and competing on the excretion side is the accurate description.

Thiocyanate, a breakdown product of glucosinolate metabolism, competes with iodide for uptake at the sodium-iodide symporter, which is the classical mechanism behind brassica goitrogens. Adequate iodine intake is therefore the relevant background for a sustained isothiocyanate load. This is textbook transport competition and needs no combination trial to state.

Isothiocyanates react with the thiol of glutathione and leave the body as mercapturic acid conjugates in urine, which is how their absorption is measured in human studies. Glutathione is therefore both the buffer that limits their reactivity and the vehicle that removes them. Same molecule, two roles, and both are settled biochemistry.

The urinary metabolite measured after isothiocyanate intake is the N-acetylcysteine conjugate, so N-acetylcysteine sits on the exit route by definition. Supplying more cysteine supports glutathione synthesis, and free thiols also quench the electrophile directly, which pulls in two directions at once. The net effect on tissue exposure has not been measured in people.

Cysteine is the limiting amino acid for glutathione synthesis, and glutathione is what conjugates an isothiocyanate. Adequacy of the precursor therefore constrains the conjugation capacity. This is pathway biochemistry, not a claim about a measured combination.

Several of the proteins induced downstream of Nrf2 signalling, including glutathione peroxidases and thioredoxin reductase, are selenoenzymes and cannot be made without selenium. An inducer without the element produces transcripts the body cannot fully translate into activity. Selenium adequacy is a precondition here rather than an additive effect.

Curcumin and isothiocyanates both act as electrophiles that modify Keap1 cysteines and increase phase II enzyme expression in cell and animal models. Two inputs to the same switch is a real overlap and a reason formulators combine them. Whether the combination adds anything measurable in a person is unresolved.

Quercetin influences the same antioxidant response element signalling that isothiocyanates act on, and the two are frequently combined in in vitro antimicrobial and redox screens. The grounding is cell-level. No human combination data exists.

Resveratrol appears alongside isothiocyanates in the preclinical literature on inducers of the antioxidant response. That places them on one pathway in cells. It is a mechanistic pairing at low confidence and should be labelled as such.

Lipoic acid carries a reducible dithiolane ring and participates in cellular thiol redox cycling, the same chemistry that isothiocyanate electrophiles engage. Direct thiol reaction can also blunt the electrophile before it reaches a target. Direction of the net effect has not been measured.

Ascorbate regenerates tocopherol and supports the cellular reducing environment that Nrf2-driven enzymes maintain. It works downstream of an isothiocyanate rather than alongside it. The relationship is redox housekeeping, not a demonstrated combination effect.

Tocopherol handles lipid radicals in membranes while the enzymes induced downstream of an isothiocyanate work largely in the cytosol. The two occupy different compartments of the same defence, which is a complementarity rather than an overlap. Not measured together.

Some lactic acid bacteria show myrosinase-like activity on glucosinolates in fermentation and culture work, which is part of why fermented brassica products differ from raw ones. Strain-level capacity is uneven and not established for any commercial strain in particular. The row is a labelled possibility.

If gut bacteria are the ones hydrolysing glucosinolates in cooked food, then anything that shifts that community shifts conversion. Inulin is a fermentable substrate that does so. The chain of reasoning is sound and the endpoint has not been measured.

Resistant starch reaches the colon and feeds the fermenting community that carries the glucosinolate-hydrolysing capacity in the absence of plant myrosinase. That makes it an indirect input to conversion. Indirect and unmeasured, stated as such.

Volatile isothiocyanates and phenolic essential oils are studied together as vapour-phase and contact antimicrobials in food preservation, where combined activity is commonly reported. These are laboratory and food-matrix results, not effects measured in a person. The additive framing belongs to preservation chemistry.

Thymol-bearing essential oils appear alongside allyl isothiocyanate in antimicrobial packaging and food-model studies. The endpoint is microbial growth in a food or culture system. Nothing here transfers automatically to a swallowed capsule.

Allyl isothiocyanate is a strong TRPA1 agonist, which is the pungency of mustard and wasabi, while menthol acts at TRPM8 for the cooling sensation. Combining two volatile TRP agonists changes the sensory result and the irritant load on mucosa. That is a formulation consideration rather than a benefit claim.

Allyl isothiocyanate is a recognised mucous membrane irritant at concentration, and mucilaginous demulcents are the traditional way to buffer contact with an irritant preparation. This is practice from herbal formulation, not a measured pairing. Enteric or encapsulated delivery addresses the same problem differently.

Allyl isothiocyanate is volatile, lipophilic and reactive, so a lipid carrier or an inclusion complex reduces headspace loss and moderates direct mucosal contact. That is why almost nothing on the market presents it neat. Formulation chemistry, with no claim about absorption beyond what the review literature reports for isothiocyanates generally.

Metallothionein expression is regulated in concert with the antioxidant response pathway that isothiocyanates engage, and zinc is the metal that induces it. The overlap is transcriptional and documented in cells. Low confidence and no human combination data.